SARS-CoV-2 diagnostic pipeline

FIND is collating an overview of SARS-CoV-2 tests that are commercially available or in development for the diagnosis of COVID-19.

For antigen rapid diagnostic tests (Ag RDTs) and molecular point-of-care tests, we have compiled a fully searchable directory. Manufacturer performance data (sensitivity and specificity) are included, where known, alongside data from independent evaluations conducted by FIND, where applicable.

COVID-19 TEST DIRECTORY (AG RDT, MOLECULAR POC)

We are continuing to build this database, and will be adding other test types as well as data from independent evaluations by other entities.

In the meantime, a simpler listing of all other tests can still be found in our original pipeline tracker, below.

We do not guarantee that this is a comprehensive list, since the information below has been submitted voluntarily by test suppliers and is not independently verified. If you have any queries or wish for us to make updates in the pipeline, please contact us.

If you would like your test to be included in the pipeline, please click on this button to download the form. Submission form

To know more about the FIND evaluations of submitted SARS-CoV-2 tests, click here. ongoing test evaluations

EUA: Emergency Use Authorization — HSA: Health & Safety/Sciences Authority — MFDS: Ministry of Food & Drug Safety — MOH: Ministry of Health — MHRA: Medicines & Health Care Products Regulatory Agency — NRA: National Regulatory Authority — RUO: Research Use Only — TGA: Therapeutic Goods Administration — WHO EUL: World Health Organization Emergency Use Listing